In the US, Diflunisal (diflunisal systemic) is a member of the following drug classes: Nonsteroidal anti-inflammatory drugs, salicylates and is used to treat Osteoarthritis, Pain and Rheumatoid Arthritis.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Analgesic, antipyretic and anti-inflammatory agent
Non-steroidal anti-inflammatory drug, NSAID
[1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-
- Diflunisalum (Latin)
- Diflunisal (German)
- Diflunisal (French)
- Diflunisal (Spanish)
- Diflunisal (OS: USAN, JAN, DCF, DCIT, BAN)
- MK 647 (IS)
- Diflunisal (PH: BP 2016, Ph. Eur. 8, USP 38)
- Diflunisalum (PH: Ph. Eur. 8)
Chin Teng, Taiwan
- Diflunisal Teva
Teva, United States
Merck Sharp & Dohme, Lithuania
- Maxipan (Diflunisal and Naproxen)
- Ning Hu Shu Xin
Shapu Aisi Pharmaceutical, China
- Rheumafen forte (Diflunisal and Diclofenac)
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|DCIT||Denominazione Comune Italiana|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.